What is a stock summary page? Click here for an overview.
Business Description
Cyfuse Biomedical KK
ISIN : JP3311800001
Description
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.21 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -1.22 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.47 | |||||
| Beneish M-Score | -0.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -25.8 | |||||
| 3-Year EBITDA Growth Rate | -19.6 | |||||
| 3-Year EPS without NRI Growth Rate | -17.9 | |||||
| 3-Year FCF Growth Rate | -22 | |||||
| 3-Year Book Growth Rate | 23.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.52 | |||||
| 9-Day RSI | 54.99 | |||||
| 14-Day RSI | 61.39 | |||||
| 3-1 Month Momentum % | 74.2 | |||||
| 6-1 Month Momentum % | 38.47 | |||||
| 12-1 Month Momentum % | 13.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.11 | |||||
| Quick Ratio | 6.02 | |||||
| Cash Ratio | 5.86 | |||||
| Days Inventory | 675.01 | |||||
| Days Sales Outstanding | 37.03 | |||||
| Days Payable | 40.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 | |||||
| Shareholder Yield % | 0.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.3 | |||||
| Operating Margin % | -1285.67 | |||||
| Net Margin % | -1103.48 | |||||
| FCF Margin % | -955.57 | |||||
| ROE % | -21.28 | |||||
| ROA % | -16.37 | |||||
| ROIC % | -97.77 | |||||
| 3-Year ROIIC % | -52.35 | |||||
| ROC (Joel Greenblatt) % | -293.21 | |||||
| ROCE % | -18.85 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 149.11 | |||||
| PB Ratio | 3.18 | |||||
| Price-to-Tangible-Book | 3.22 | |||||
| EV-to-EBIT | -10.38 | |||||
| EV-to-EBITDA | -10.38 | |||||
| EV-to-Revenue | 112.53 | |||||
| EV-to-FCF | -11.24 | |||||
| Price-to-Net-Current-Asset-Value | 3.61 | |||||
| Price-to-Net-Cash | 3.82 | |||||
| Earnings Yield (Greenblatt) % | -9.63 | |||||
| FCF Yield % | -6.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cyfuse Biomedical KK Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 60.882 | ||
| EPS (TTM) (円) | -84.843 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 183.65 | ||
| 14-Day RSI | 61.39 | ||
| 14-Day ATR (円) | 104.684721 | ||
| 20-Day SMA (円) | 984.1 | ||
| 12-1 Month Momentum % | 13.16 | ||
| 52-Week Range (円) | 430 - 1412 | ||
| Shares Outstanding (Mil) | 8.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cyfuse Biomedical KK Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cyfuse Biomedical KK Stock Events
| Event | Date | Price (円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cyfuse Biomedical KK Frequently Asked Questions
What is Cyfuse Biomedical KK(TSE:4892)'s stock price today?
The current price of TSE:4892 is 円1160.00. The 52 week high of TSE:4892 is 円1412.00 and 52 week low is 円430.00.
When is next earnings date of Cyfuse Biomedical KK(TSE:4892)?
The next earnings date of Cyfuse Biomedical KK(TSE:4892) is .
Does Cyfuse Biomedical KK(TSE:4892) pay dividends? If so, how much?
Cyfuse Biomedical KK(TSE:4892) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers